Skip to main content

Daniel P. O’Day

Equibles does not estimate personal net worth.

Get an email with a short summary when Gilead Sciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get GILD alerts

About Daniel P. O’Day

Daniel P. O’Day is recorded as CEO at Gilead Sciences, Inc. (GILD). The proxy statement of Gilead Sciences, Inc. reports total compensation of $28,437,198 for Daniel P. O’Day in fiscal 2025, including a base salary of $1,795,192. Disclosed compensation is on record for 7 fiscal years. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Robin L. Washington (CFO), Diane E. Wilfong (Chief Accounting Officer), Erin Burkhart (Chief Accounting Officer) and 7 others.

Affiliation history

Company network

Leadership on record at Gilead Sciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Gilead Sciences, Inc. (GILD) $1,795,192 $28,437,198
2024 Gilead Sciences, Inc. (GILD) $1,771,201 $23,689,392
2023 Gilead Sciences, Inc. (GILD) $1,740,962 $22,607,690
2022 Gilead Sciences, Inc. (GILD) $1,691,154 $21,621,253
2021 Gilead Sciences, Inc. (GILD) $1,650,000 $19,229,466
2020 Gilead Sciences, Inc. (GILD) $1,702,885 $18,998,095
2019 Gilead Sciences, Inc. (GILD) $1,267,692 $29,107,854

Recent activity

No call appearances or filed executive changes recorded yet.